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Abstract: In recent scientific literature, oral infections and systemic manifestations, or correlations 
between oral health and systemic diseases are a topic of discussion. Porphyromonas gingivalis is one 
of the bacteria implicated in the biofilm formation of bacterial plaque, and plays an important role 
in the progression of periodontal disease. In this systematic review authors have evaluated the 
literature of the last 10 years on P. gingivalis and all the systemic implications proven. This study 
therefore evaluates all the districts of the organism in which this bacterium may have implications. 
From the results it emerges that P. gingivalis has implications in the onset of different systemic 
pathologies, including rheumatoid arthritis, cardiovascular pathologies, and neurodegenerative 
pathologies. Surely, understanding the mechanisms of diffusion of this bacterium, it would be 
possible to prevent a series of pathologies. Thus, putting the dentist clinician at the center of 
prevention for these diseases. 
Keywords: Porphyromonas gingivalis; periodontitis; bacteremia; LPS; brain diseases; 
neurodegenerative diseases; cardiovascular diseases; arthritis; oral health 
 
1. Introduction 
1.1. Rationale 
Oral health has an important role with regard to systemic health, this is reflected in the scientific 
literature. There are numerous correlations between problems or oral alterations and systemic health 
of the patient [1–5]. In particular, the implications of chronic oral inflammation, such as 
periodontitis, may be different [6]. Having both an influence on the course of oral and general 
conditions. The correlations do not seem to be very clear, and the literature on the subject is 
numerous. Periodontal disease includes gingivitis and periodontitis, pathologies that recognize an 
essentially bacterial multifactorial aetiology with the interaction of three cofactors: 
• Host susceptibility; 
• Environmental factors; 
• Behavioral factors. 
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Bacterial plaque, although a necessary condition, is affected by the indispensable role of 
interaction with the host. Numerous local and systemic factors (e.g., diabetes) influence the clinical 
course. Gingivitis affects the gum close to the tooth (marginal gingiva) and is characterized by 
reddening of the gingival margin, edema, bleeding under mechanical stimulation, and sometimes by 
volume increases. These are completely reversible clinical pictures if adequately treated. 
Periodontitis is a group of pathologies that have in common the destruction of the tooth support 
system. They manifest themselves with a loss of attachment and bone, pocket formation, and gum 
recession. They are always preceded by gingivitis and, therefore, if the latter is prevented, it is 
possible to prevent far more serious periodontitis. 
The characteristic sign of periodontitis is the formation of the periodontal pocket associated 
with tooth mobility. In recent years, much research has focused on the mechanisms that underlie 
periodontal disease, and in particular on the condition of balance that is created between the 
immune system and bacterial biofilm. One of the bacteria present in the oral plaque biofilm is 
Porphyromonas gingivalis (P. gingivalis) [7]. P. gingivalis belongs to the phylum Bacteroidetes and is a 
nonmotile, Gram-negative, rod-shaped, anaerobic, pathogenic bacterium. It forms black colonies on 
blood agar when prelevated in the respiratory tract and the colon, it is implicated in periodontal 
disease [8,9]. It has been isolated from women with bacterial vaginosis and on brain biopsies of 
patients with Alzheimer’s disease too [10–13]. 
1.2. Objectives 
The aim of this study is to evaluate a correlation between P. gingivalis periodontal implications 
and any proved correlated systemic disease. 
2. Materials and Methods 
2.1. Protocol and Registration 
This manuscript has been registered as a Review in a Systemic Review database called 
PROSPERO. It is an International Prospective Register of Systematic Reviews about health and social 
care. Obtained PROSPERO registration number is 145886 on 04/08/2019. The main question of this 
study was elaborated following the PICOT (Population/Intervention/Comparison/Outcome/Time) 
study design [14]. 
This revision paper followed a protocol according to PROSPERO and according to PRISMA 
(Transparent Reporting of Systematic Reviews and Meta-Analyses) [15–17]. 
2.2. Eligibility Criteria 
The results obtained from the literature search were filtered, through software and manual 
screening, according to these inclusion and exclusion criteria: 
• Inclusion Criteria: 
o Human studies; 
o Information about P. gingivalis and periodontal implication; 
o Information about P. gingivalis and systemic disease; 
o In vitro and in vivo studies about P. gingivalis; 
o Last 10 years studies. 
• Exclusion Criteria: 
o In silica studies; 
o Not on human studies; 
o Not in English; 
o Not accessible title or abstract; 
o Not enough information about main question of review. 
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2.3. Information Sources 
Results have been obtained after a research and a screening on scientific international database 
as PubMed, Embase, and Web of Science. Automatic filter and platforms software have been used 
for results screening. 
2.4. Search 
Search has been conducted using this keyword on information sources: “Porphyromonas 
gingivalis” and “Systemic”. Search date is 01/07/2019.  
The database search protocol details is: “Porphyromonas gingivalis” (All Fields) and “systemic” 
(All Fields) and (Review (ptyp) and “loattrfull text” (sb) and “2009/07/01” (PDat): “2019/07/01” 
(PDat) and “humans” (MeSH Terms) and English (lang)). 
Keyword were chosen by authors after a discussion with the aim to include a larger as possible 
number of results (Figure 1). 
Population, Intervention, Comparison, Outcome (PICO) questions were: 
• Are patients who have periodontitis an increased for systemic health status compared with 
patients without periodontitis? 
• Does P. gingivalis influence systemic health in patients who have periodontitis? 
2.5. Study Selection 
The selection process was conducted by authors with the aim to include relevant studies for this 
review. After the electronic eligibility criteria applying, authors conducted a manual study selection 
independently. Selection of study conducted to this manuscript. 
2.6. Data Collection Process 
Data collection process has been conducted independently by two authors of two different 
University (L.F. (University of Naples and G.C. University of Messina). After data screening 
completion they clarified any doubt with another two expert reviewers (M.C. and L.L.). The original 
draft then was revised by a last independent author (T.T.). 
2.7. Data Items 
The following data items were considered during data collection: 
• Summary of items (Table 1): 
o Neurology; 
o Cardiology; 
o Immunology; 
o Rheumatology; 
o Diabetology; 
o Oncology; 
o Biology. 
• Investigated data items on articles (Tables 2 and 3): 
o Authors and year–article authors and year of publication (reference have been added); 
o Item–article and authors evaluated items; 
o Outcome–main results of the study; 
o Medical disease–investigated medical disease. 
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2.8. Risk of Bias in Individual Studies 
The grade of bias risk was independently considered, and in duplicate by the two independent 
reviewers at the moment of data extraction process. This revision followed the Cochrane 
Collaboration’s two-part tool for assessing risk of bias and PRISMA statement [15,16]. 
Potential causes of bias were investigated: 
• Selection bias; 
• Performance bias and detection bias; 
• Attrition bias; 
• Reporting bias; 
• Examiner blinding, examiner calibration, standardized follow-up description, standardized 
residual graft measurement, and standardized radiographic assessment. 
In this way, the possible random sequence generation, the possible allocation concealment, the 
possibility of blinding of participants and personnel, the possible presence of having incomplete 
outcome data and other biases were all considered and evaluated. 
This method applied by the two reviewers was valuable for giving to each study a level of bias. 
Then, the selected papers were classified with low, moderate, high and unclear risk. 
2.9. Summary Measures 
Accordingly to PRISMA statement, principal summary of measures has been showed in Table 
1. 
Table 1. Table representing all periodontal and Porphyromonas gingivalis correlation on systemic 
condition. 
Neurology 
Chronic inflammation and Alzheimer’s Disease (AD) 
P. gingivalis and AD 
Cardiology 
Atherosclerosis risk factor and periodontal disease. 
PD and Cardiovascular Disease (CVD), Age, Smoking, Diabetes 
Chronic infection and Coronary Heart disease (CHD) 
Periodontal Bacteria and atherosclerosis 
Cytokines and coronary heart disease 
Immunology 
Periodontitis an immune response 
Antigenic target for P. gingivalis 
Microbiome, Periodontal disease 
Serum lipoprotein concentration, endothelial permeability, lipoprotein binding in 
intimate 
Periodontal disease and AIDS progression 
Rheumatology 
Rheumatoid Arthritis 
Osteoporosis 
Diabetology 
Diabetes mellitus 
Insulin resistance 
Oncology 
P. gingivalis and Oral Cancer (OC) 
Bacterial infection and Pancreatic Cancer (PC) 
Biology 
Virus and periodontal disease correlation 
Bacteriaemias and systemic disease 
Periodontal disease and Systemic diseases 
P. gingivalis biology 
Oral bacteria and extraoral infections 
2.10. Synthesis of Results 
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The summary of the results was carried out manually by the authors, after reading the title, 
abstract and full text of each article. 
2.11. Risk of Bias across the Studies 
Risk of bias across the studies has been evaluated according to PRISMA guidelines. Limitation 
of detailed design, inconsistency, indirectness, imprecision, and publication bias was evaluated 
during this workflow. 
2.12. Additional Analysis 
Additional information about periodontitis and P. gingivalis was performed. A literature search 
provided results about P. gingivalis biology and periodontitis physiopathology. 
3. Results 
3.1. Study Selection 
Results were obtained according to the Materials and Methods instructions. Obtained results 
were 632, using paragraph 2.4 keywords. Subsequently, according to eligibility criteria, results were 
screened. Authors decided to maintain only the last 10 years results, because of novelty and 
accuracy on the diagnostics method, and quality of results due to new technologies, 395 results 
remained after this first screening. Only 213 studies on human have been considered, and authors 
analyzed full text (198) and English articles (194). The last step to complete study results selection 
was to compare only the review articles type. Only 21 results, after a reading and a manual authors 
screening resulted eligible for this study (Figure 1). 
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Figure 1. PRISMA flow chart. 
3.2 Study Characteristics and Results of Individual Studies 
Results of individual studies are listed below in Table 2. 
Table 2. Table of main results and item investigated on reviews. 
Authors and 
Year Items Outcomes 
Dominy et al., 
2019 [10] 
P. gingivalis and 
Alzheimer’s disease 
P. gingivalis and gingipains were identified in the brain of 
Alzheimer’s patients. Gingipain inhibition reduced the bacterial 
load of P. gingivalis infection. 
Bale et al., 
2017 [18] 
Serum lipoprotein 
concentration, endothelial 
permeability, lipoprotein 
binding in intima 
This study supports that Periodontal disease (PD) could be 
associated with arterial disease 
Tiantian et al., 
2016 [19] 
Virus and periodontal 
disease correlation 
P. gingivalis can interact with a variety of bacterium viruses 
which may be the reason for chronic periodontitis and systemic 
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disease 
Gholizadeh et 
al., 2016 [20] 
P. gingivalis and Oral 
Cancer (OC) 
PD, systemic condition and head and neck cancer (HNC) could 
be correlated 
Chistiakov et 
al., 2016 [21] 
PD and Cardiovascular 
Disease (CVD), Age, 
Smoking, Diabetes 
Periodontal pathogens, virulence factors and bacterial 
endotoxins are correlated with CVD development as 
endothelial dysfunction, systemic inflammation, oxidative 
stress, lipid accumulation, vascular remodeling, and 
atherothrombosis. 
Alfakry et al., 
2016 [22] 
Chronic infection and 
Coronary Heart disease 
(CHD) 
Inflammation activates endogenous degradation pathways 
mediated by immune responses and it takes to destructive 
cellular mechanism. Matrix metalloproteinases (MMPs) can 
activate immune response, with extracellular matrix 
components degradation. These mechanisms could lead to 
CHD. 
Xie 2015 [23] P. gingivalis biology 
P. gingivalis outer membrane produces vesicles. These vesicles 
can communicate with other member of microbial biofilm and 
with host cells. 
Wu et al., 2014 
[24] 
Chronic inflammation and 
Alzheimer’s disease (AD) 
Systemic inflammations are correlated with neuroinflammation 
and inflammation of the brain. Diabetes [25], cardiovascular 
disease, or PD could be implicated with AD. Chronic 
periodontitis can be a significant source of systemic 
inflammation and so AD too. 
Scher et al., 
2014 [26] 
Periodontitis an immune 
response 
There is a correlation between PD a rheumatoid arthritis (RA). 
Circulating antibodies against periodontopathic bacteria, as P. 
gingivalis, and their associated inflammatory response have 
been found in RA affected patients. Smoke habits seems to be a 
co-associated factor for RA development. 
Grover et al., 
2014 [27] 
Antigenic target for P. 
gingivalis 
Microbial genome sequencing and bioinformatics could lead to 
a vaccine development for P. gingivalis. 
Brusca et al., 
2014 [28] 
Microbiome and RA 
Presence of bacteria in mucosal surfaces can alter local and 
systemic immune responses and could cause joint inflammation  
Reyes et al., 
2013 [29] 
Periodontal Bacteria and 
atherosclerosis 
Periodontal bacteria can disseminate from oral cavity to 
systemic vascular tissue, could live in those tissues and damage 
cells. These bacteria can induce atherosclerosis. 
Michaud 2013 
[30] 
Bacterial infection and 
Pancreatic Cancer (PC) 
Helicobacter pylor may be a risk factor for PC, other bacteria that 
should be considered is P. gingivalis. Periodontal disease and P. 
gingivalis play a role on carcinogenesis of pancreas. Systemic 
inflammation markers can be found due to oral bacteria in the 
blood. 
Han et al., 
2013 [31] 
Oral bacteria and extraoral 
infections 
Oral commensals and pathogens could support extra-oral 
infections and inflammations. Some of these conditions are 
represented by CVD, adverse pregnancy outcomes, RA, 
inflammatory bowel disease, colorectal cancer, respiratory 
infection, and organ inflammation or infections 
El-Shinnawi et 
al., 2013 [32] 
Cytokines and coronary 
heart disease 
TNF-alpha gene polymorphism is linked to periodontal 
attachment loss in patients with CHD. P. gingivalis and oral 
inflammation could be associated to insulin resistance and 
arthritis too. 
Imai et al., 
2011 [33] 
Periodontal disease and 
AIDS progression 
Epigenetic regulation is involved in maintenance and 
reactivation of HIV-1 by periodontopathic bacteria. 
Huck et al., 
2011 [34] 
Atherosclerosis risk factor 
and periodontal disease. 
PD negatively influences cardiovascular status. Severe form of 
Atherosclerosis is associated to P. gingivalis.  
McNicol et al., 
2010 [35] 
Bacteriaemias and 
systemic disease 
Atherothrombotic disorders may be due to persistent 
bacteriaemia and oral infection. Bacteriaemias occur frequently 
in PD patients. Some bacteria, as P. gingivalis can activate 
platelets in vitro.  
Inaba et al., 
2010 [36] 
Periodontal disease and 
systemic diseases 
Periodontal disease is associated with CVD, preterm delivery of 
low birth weight, diabetes mellitus, respiratory diseases, and 
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osteoporosis. 
Hayashi et al., 
2010 [37] 
Periodontal disease and 
systemic diseases 
P. gingivalis induce a chronic inflammation, this status could 
lead to infection, that is correlated with systemic diseases as 
diabetes, preterm birth, stroke, and CVD. P. gingivalis stimulate 
chronic inflammation and plaque accumulation and has a role 
on Toll-like receptors signaling. 
Detert et al., 
2010 [38] 
Periodontal disease and 
rheumatoid arthritis 
The existence of rheumatic or other inflammatory disease may 
promote periodontal disease, and periodontal disease maintains 
systemic diseases. P. gingivalis plays an important role on 
citrullination. 
3.3. Synthesis of Results 
According to Tables 1 and 3, authors defined a scheme to better clarify periodontitis systemic 
correlations (Figure 2) [39]. 
Table 3. Medical disease subdivided study. 
Authors and Year Items Medical Disease 
Bale et al., 2017 [18] 
Serum lipoprotein concentration, endothelial 
permeability, lipoprotein binding in intima 
Cardiology 
Chistiakov et al., 
2016 [21] 
PD and cardiovascular disease (CVD), age, smoking, 
diabetes 
Alfakry et al., 2016 
[22] Chronic infection and coronary heart disease (CHD) 
Reyes et al., 2013 
[29] Periodontal bacteria and atherosclerosis 
El-Shinnawi et al., 
2013 [32] Cytokines and coronary heart disease 
Huck et al., 2011 
[34] Atherosclerosis risk factor and periodontal disease. 
McNicol et al., 2010 
[35] Bacteriaemias and systemic disease 
Inaba et al., 2010 
[36] Periodontal disease and systemic diseases 
Hayashi et al., 2010 
[37] Periodontal disease and systemic diseases 
Scher et al., 2014 
[26] Periodontitis an immune response Rheumatology 
Han et al., 2013 [31] Oral bacteria and extraoral infections 
El-Shinnawi et al., 
2013 [32] 
Cytokines and coronary heart disease Diabetology 
Gholizadeh et al., 
2016 [20] 
P. gingivalis and oral cancer (OC) Oncology 
Tiantian et al., 2016 
[19] 
Virus and periodontal disease correlation 
Biology and 
Immunology 
Grover et al., 2014 
[27] 
Antigenic target for P. gingivalis 
Michaud 2013 [30] Bacterial infection and pancreatic cancer (PC) 
Brusca et al., 2014 
[28] Microbiome and RA 
Imai et al., 2011 [33] Periodontal disease and AIDS progression 
Dominy et al., 2019 
[10] P. gingivalis and Alzheimer’s disease Neurology 
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Wu et al., 2014 [24] Chronic inflammation and Alzheimer’s disease (AD) 
 
Figure 2. Periodontal disease and systemic diseases (for kind concession of Dr. Luca Fiorillo). 
3.4. Risk of Bias 
A risk of bias analysis has been performed according to PRISMA guidelines and results have 
been shown in the Table 4. 
Table 4. Risk of bias risk. 
Authors and Year 
Risk of Bias 
Unclear Low Moderate High 
Dominy et al., 2019 [10]   ✓  
Bale et al., 2017 [18]   ✓  
Tiantian et al., 2016 [19]   ✓  
Gholizadeh et al., 2016 [20]  ✓   
Chistiakov et al., 2016 [21]   ✓  
Alfakry et al., 2016 [22]    ✓ 
Xie 2015 [23]    ✓ 
Wu et al., 2014 [24]   ✓  
Scher et al., 2014 [26]    ✓ 
Grover et al., 2014 [27]   ✓  
Brusca et al., 2014 [28]   ✓  
Reyes et al., 2013 [29]   ✓  
Michaud 2013 [30]    ✓ 
Han et al., 2013 [31]  ✓   
El-Shinnawi et al., 2013 [32]  ✓   
Imai et al., 2011 [33]   ✓  
Huck et al., 2011 [34]   ✓  
McNicol et al., 2010 [35]   ✓  
Inaba et al., 2010 [36]   ✓  
Hayashi et al., 2010 [37]   ✓  
Detert et al., 2010 [38]   ✓  
3.5. Additional Analysis 
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Porphyromonas gingivalis is considered the second most studied parodontal pathogen, after 
Aggregatibacter actinomycetemcomitans. This is a gram-negative bacterium; it is a bacterium that is 
often found in the form of a coccobacterium, or rod. It is part of the group of black-pigmented 
Bacteroides. The bacteria of this group form black-brown colonies on blood agar plates. They were 
almost immediately associated with periodontal disease, within this family of asaccharolytic species 
(P. gingivalis), intermediate species and highly saccharolytic species (Prevotella melaninogenica). They 
were immediately of scientific interest as they produce a series of particularly high virulence factors. 
In fact, P. gingivalis is able to produce collagenase, a series of proteases, hemolysins, endotoxins, fatty 
acids, ammonia, hydrogen sulfide, indole and others; furthermore, this bacterium is able to inhibit 
the polymorphonuclear migration through the endothelial barrier. This species is present in patients 
with periodontal disease, but the quantities are reduced, compared to patients who have aggressive 
forms of this disease. P. gingivalis is able to attack epithelial cells of the gingival mucosa, and 
endothelial cells. This fact can be found above and within the epithelial cells, due to the use of 
fimbriae by the bacterium. Following tooth brushing and the formation of the glycoprotein of dental 
enamel, a bacterial biofilm starts to form on it. Among the first colonizers we certainly recognize the 
Streptococcus oralis and Streptococcus mitis; Streptococcus gordonii and Streptococcus oralis; and 
Streptococcus sanguis. Subsequently a complex process of bacterial aggregation takes place up to the 
Fusobacterium nucleatum, which guarantees, directly or through Treponema denticola, the adhesion of 
P. gingivalis. P. gingivalis is a late colonizer, like Actinomyces actinomycetemcomitans or the 
intermediate Prevotella [40]. It should also be emphasized that the causes of periodontal disease can 
be multiple. Some factors, such as biomechanical factors, may have an important role in the course of 
this multi-factorial pathology [41–44]. 
4. Discussion 
4.1. Summary of Evidence 
During the analysis of the results we carefully extrapolated all the results, as evident in the 
previous section, and we also evaluated the conclusions, and future perspectives of each article. 
These are reported below, and were discussed by the authors, according to Table 1 scheme. 
4.1.1. Neurology 
According to Dominy et al. [10] P. gingivalis has been identified on Alzheimer’s patients 
histologies. Toxic proteases, called gingipains have been found too. Gingipains are neurotoxic, and 
its inhibition reduces the bacterial load of P. gingivalis. The small-molecule inhibitors designed by 
authors, could inhibit gingipains and so block Aβ1–42 (component of amyloid plaques) production 
by P. gingivalis. Inhibiting P. gingivalis can reduce neurotoxicity, and this inhibitor could be valuable 
for treating brain colonization. According to We et al. [24] PD and chronic systemic inflammation 
could be correlated with neuroinflammation and AD. Periodontitis can be correlated to AD and 
other neurodegenerative diseases. 
4.1.2. Cardiology 
According to Bale et al. [18] periodontal disease can influence the atherosclerosis pathogenesis 
triad; PD is caused by high-risk pathogens for arterial disease, so dental community should manage 
PD reducing so cardiovascular disease that is one cause of morbidity and mortality on general 
population. According to Chistiakov et al. [21] there is an important correlation between PD and 
CVD. All periodontal disease characteristics as bacterial toxins, virulence factor, and immunological 
alteration could develop CVD. In summary, clinicians could prevent CVD and heart disease just 
preventing PD and PD products. Periodontal therapy could be the first step on cardiovascular 
disease therapy [45]. According to authors, a dentist should be on the first line for CVD therapy and 
prevention. In another review study of Alfakry et al. [22] a coronary heart disease correlation has 
been showed. According to authors, PD and endogenous degradation mechanisms could lead to 
tissue destruction. According to Reyes et al. [29] despite no bacteria have been found on atheromas, 
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periodontal bacteria could diffuse through systemic vascular tissue, and cause atherosclerosis. 
Periodontal bacteria isolated from human atheromas did not cause disease on animal models, not 
respecting Koch postulates. Preventing PD and periodontal chronic inflammation could be a first 
therapeutic step for atherosclerosis interdiction. According to Huck et al. [34] periodontal disease 
and P. gingivalis infection could lead to atherosclerosis progression. There is a link between these 
pathologies, and periodontal treatment could be a benefit to systemic condition. 
According to McNicol and Israels [35] bacteriaemia is frequent in PD patients, and it is the basis 
of atherothrombosis development. In their study they evaluate the bacteria ability to activate 
platelets. According to Inaba and Amano [36] oral bacteria play an important role on systemic 
disease. Hayashi et al. [37] evaluated different systemic diseases correlated to periodontal disease 
and P. gingivalis infection. P. gingivalis can induce chronic inflammation and maintain this status at 
sites distant from oral infection. 
In a recent publication from the study of coronary diseases and periodontal disease, it was 
shown that high levels of the group of periodontal pathogens defined as the sum of five pathogens 
examined (Actinomyces actinomicetemcomitans, Tannerella forsythia, P. gingivalis, Prevotella intermedia, 
and Treponema denticola) and high levels of colonization of A. actinomicetemcomitans were 
significantly associated with cardiovascular disease in a correct multivariate analysis. It has also 
been shown that endothelial cells can be damaged by the ability of P. gingivalis to adhere, invade and 
proliferate in endothelial coronary cells. It is possible that this phenomenon may interfere with the 
physiological function of vasodilation due to the damage caused to both endothelial and smooth 
muscle cells. When in vitro data were translated into a cohort study, this association was further 
strengthened and it was shown that patients with periodontitis had significant impairment of 
flow-mediated dilation [2,4,10,39–46]. 
4.1.3. Rheumatology 
Scher et al. [26] showed how there is a correlation between some immunological systemic 
disease and PD. This should be caused by circulating bacterial antibodies that lead to systemic 
inflammation. PD has been correlated with RA and smoking habits. Han et al. [31] showed a large 
list of systemic alteration due to oral microbioma and periodontal infections. Adverse pregnancy 
outcomes, rheumatoid arthritis, inflammatory bowel disease and other pathologies, could be caused 
by P. gingivalis, Streptococcus mutans, Campylobacter rectus, or Fusobacterium nucleatum. P. gingivalis is 
one of the extra-oral prone bacteria. Evaluate and quantify extraoral pathogens levels could predict 
disease potential. According to Detert et al. [38] rheumatoid factor and the anticyclic citrullinated 
peptide antibody are present in PD and RA. P. gingivalis plays a role on citrullination. 
4.1.4. Diabetology 
According to El-Shinnawi and Soory [32] PD affected patients present other inflammatory 
condition as CHD, RA, or insulin resistance. For example, IL-1, IL-6, and TNF-alpha that are linked 
to periodontal disease progression, are associated to insulin resistance too. Periodontal treatment 
could be essential for systemic inflammation prevention. 
4.1.5. Oncology 
Gholizadeh et al. [20] in their review evaluated the correlation between oral chronic 
inflammation and OC development [47–49]. P. gingivalis and other microbes’ species are implicated 
on PD, which could be an etiological factor in certain cancers. A multicenter study of 405 cases of 
pancreatic cancer and 416 controls found that the titers of anti-P. gingivalis antibodies were higher in 
patients with pancreatic cancer than in healthy subjects, suggesting that the oral microbiota, in 
particular that of the periodontal patients, may be considered a potential biomarker of human 
diseases. A statistically significant association between squamous cell carcinoma of the head and 
neck and periodontal disease has also been reported, suggesting that periodontal disease may be an 
independent risk factor, with practical implications for prevention, early diagnosis, and treatment, 
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in the search for a possible improvement in the prognosis of the disease. Understanding 
host-microbe interaction and related cause-effect mechanisms has paved the way for a broader 
understanding of the role of the microbiome in health and disease conditions, providing new 
therapeutic approaches in clinical practice [47–53].  
4.1.6. Biology and Immunology 
In a Tiantian et al. [19] study authors showed how viruses and bacteria are associated in 
periodontal disease [50], therefore periodontal disease and viral infection could develop systemic 
disease too. P. gingivalis and a virus interaction could be studied to provide a new idea for patient’s 
treatment. Xie [23] showed some biological mechanisms of P. gingivalis. P. gingivalis is one of the 
responsible of chronic periodontitis. Its products, as vesicles, could be the key to understand some 
communicative, diffusion mechanisms of P. gingivalis and its systemic implications. Grover et al. [27] 
identified P. gingivalis as one of the responsible for PD. Knowing all virulence factors should provide 
a potential antigenic target for a periodontal vaccine.  
According to Brusca et al. [28] mucosal sites exposed to bacteria represent the initial site of 
autoimmune generation, identify biomarkers and therapeutic approaches on RA are the future 
prospective of this study. Michaud et al. [30] believe that the complex interplay between host 
immune response, bacteria, and environmental factors could lead not only to gastric cancer, but to 
pancreatic cancer too. Bacteriaemia preventing could freeze some host immunological mechanisms. 
An interesting study of Imai and Ochiai [33] revealed how some periodontal bacteria could lead to 
HIV-1 maintenance, latency, and reactivation. Periodontal disease so could accelerate acquired 
immune deficiency syndrome (AIDS) in infected patients. The prevention of periodontal disease, 
once again, can slow down a systemic pathology and improve the outcome of these diseases. 
Surely the discussion of these results makes us understand how the perspectives are important 
in the field of prevention and systemic pathologies. Since periodontitis has such a crucial role in the 
development and onset of other pathologies, the results show how much the dentist has to play a 
crucial role in the diagnosis, therapy, and prevention of this. 
4.2. Limitations 
The major limitation of this study was represented by the fact of not having univocal results, on 
which it is possible to perform a statistical analysis. The results of the review were in fact purely 
descriptive/epidemiological, of what the systemic pathologies connected in their etiopathogenesis to 
periodontal disease are or may be. Since it is a revision of reviews, it was also not possible to 
calculate the risk of bias on an individual basis. 
5. Conclusions 
As could be seen from the results, oral health, and in particular, oral pathology, could have 
important systemic repercussions. The state of constant inflammation, or even the bacterial blood 
circulation or bacterial products, could be a further cause of system pathologies. Preventing negative 
oral conditions can be a good starting point for the clinician to achieve good general health. 
Moreover, oral manifestations can be useful to diagnose some pathologies early, or they can 
represent one of the first steps of some chronic pathologies. 
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